A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2020-03-11
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability, treatment effect on abdominal pain, and dose
response of MD-7246 administered orally to patients with diarrhea-predominant irritable bowel
syndrome (IBS-D).